Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dimitrov

Showing results (381-390 of 442) with videos related to

Pageof 45
Sort By:
Science Translational Medicine|August 9, 2019
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse modelKim Anthony-Gonda, Ariola Bardhi, Alex Ray, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
Journal of Virology|August 17, 2004
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibodyMei-Yun Zhang, Xiaodong Xiao, Igor A Sidorov, et al.
Plos Pathogens|November 6, 2009
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infectionKatharine N Bossart, Zhongyu Zhu, Deborah Middleton, et al.
Mabs|August 8, 2024
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancerXiaojie Chu, Seungmin Shin, Du-San Baek, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexesMaxime Moulard, Sanjay K Phogat, Yuuei Shu, et al.
NPJ Vaccines|December 20, 2024
Establishing an immune correlate of protection for Nipah virus in nonhuman primatesV H Leyva-Grado, D Promeneur, K N Agans, et al.
Blood|December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemiaWaleed Haso, Daniel W Lee, Nirali N Shah, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Pageof 45

Showing results (381-390 of 442) with videos related to

Sort By:
Pageof 45
Science Translational Medicine|August 9, 2019
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse modelKim Anthony-Gonda, Ariola Bardhi, Alex Ray, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
Journal of Virology|August 17, 2004
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibodyMei-Yun Zhang, Xiaodong Xiao, Igor A Sidorov, et al.
Plos Pathogens|November 6, 2009
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infectionKatharine N Bossart, Zhongyu Zhu, Deborah Middleton, et al.
Mabs|August 8, 2024
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancerXiaojie Chu, Seungmin Shin, Du-San Baek, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexesMaxime Moulard, Sanjay K Phogat, Yuuei Shu, et al.
NPJ Vaccines|December 20, 2024
Establishing an immune correlate of protection for Nipah virus in nonhuman primatesV H Leyva-Grado, D Promeneur, K N Agans, et al.
Blood|December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemiaWaleed Haso, Daniel W Lee, Nirali N Shah, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Pageof 45